Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.3' was added to the study history, replacing the previous 'Revision: v3.6.2'. This reflects an updated platform release recorded in the version history.
    Difference
    0.0%
    Check dated 2026-07-11T00:08:13.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    A new history entry was added for 2026-06-26 indicating a Study Status update with version 142 and Revision: v3.6.2, and an earlier 2026-02-20 entry as well as Revision: v3.6.0 were removed.
    Difference
    0.1%
    Check dated 2026-06-27T00:53:15.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    The record now shows that the study is not enrolling participants, and the history includes a new revision (v3.6.0) replacing the prior revision (v3.5.5).
    Difference
    0.1%
    Check dated 2026-06-12T17:33:04.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The history now includes a new latest revision tag v3.5.5, while the previous revision v3.5.4 is removed from the list.
    Difference
    0.0%
    Check dated 2026-06-05T16:26:05.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The history now shows a new site revision, v3.5.4, replacing the prior v3.5.3. This indicates a small update to the page's release notes in the history log.
    Difference
    0.0%
    Check dated 2026-05-15T06:16:12.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page revision/version label was applied (switching from v3.5.2 to v3.5.3). This reflects a site software/version change rather than a change to the trial’s recorded information.
    Difference
    0.0%
    Check dated 2026-04-23T21:53:39.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.